What formulations for CD/LD are approved and available for PD, and for once a person with PD begins to experience significant “off time” on CD/LD. What is your approach to minimizing deterioration in clinical symptoms?

What formulations for CD/LD are approved and available for PD, and for once a person with PD begins to experience significant “off time” on CD/LD. What is your approach to minimizing deterioration in clinical symptoms?

What formulations for CD/LD are approved and available for PD, and for once a person with PD begins to experience significant “off time” on CD/LD. What is your approach to minimizing deterioration in clinical symptoms?


Created by

CMEducation Resources iQ&A Parkinson’s Disease (PD) Medical Intelligence Zone

Related Presenters

John Morgan, MD, PhD

John Morgan, MD, PhD

Professor and DirectorMovement & Memory Disorder ProgramsDepartment of NeurologyMedical College of GeorgiaAugusta UniversityAugusta, Georgia